DANIEL J. MITCHELL

Insider Reports History

Signature
/s/ C. Jeffrey Dekker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DANIEL J. MITCHELL:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARCA biopharma, Inc. Director Common Stock 611 $1,528 $2.50 30 Jan 2024 Direct
ARCA biopharma, Inc. Director Stock Option (right to buy) 6,000 30 Jan 2024 Direct

Insider Reports Filed by DANIEL J. MITCHELL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABIO ARCA biopharma, Inc. 30 Jan 2024 1 $0 4 Director 31 Jan 2024, 16:25
ABIO ARCA biopharma, Inc. 15 Dec 2022 1 $0 4 Director 19 Dec 2022, 15:24